Interleukin 2, soluble interleukin 2 receptor, and interferon-γ in the suction blister fluids from psoriatic skin
✍ Scribed by H. Takematsu; H. Tagami
- Publisher
- Springer-Verlag
- Year
- 1990
- Tongue
- English
- Weight
- 373 KB
- Volume
- 282
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
✦ Synopsis
Psoriasis represents inflammatory skin disorders characterized by significant changes in cellular immunity, particularly exhibiting alterations in T lymphocyte-related functions. Early psoriatic lesions have been reported to show an infiltration of activated helper T cells. Elevated levels of interleukin 2 (IL-2), IL-2 receptor (IL-2R), and interferon-~ (INF-?) are associated with an early activation of T cells. To examine local activation of T cells in psoriatic skin, the amounts of activated T cell products, IL-2, secretory form of IL-2R (sIL-2R) and INF-~ were measured in the fluids of suction blisters raised on psoriatic skin. sIL-2R levels were significantly elevated in the suction blister fluids raised on psoriatic involved skin compared with those on normal and psoriatic uninvolved skin. On the other hand, neither IL-2 or IFN-~ was detected in the suction blister fluids either from normal, psoriatic uninvolved, or involved skin. However, we could detect IFN-~ and IL-2 in the psoriatic scale extracts. Although we failed to detect IL-2 and IFN-~ in the suction blister fluids, the increased levels of sIL-2R in the suction blister fluids from the psoriatic lesional skin indicate local activation of T cells in psoriatic lesional skin.
📜 SIMILAR VOLUMES
In a previous study, we used an enzyme-linked immunosorbent assay to measure soluble human interleukin-2 receptors (IL3R), and found that when activated lymphocytes produce cell-associated IL-2R, they also release a soluble form of IL3R into culture supernatants in vitro. Soluble IL-2R have also bee
## Background: The serum markers ca125, tissue polypeptide specific antigen (tps), and soluble interleukin-2 receptor alpha (sil-2ralpha) concentrations were determined in sera, cyst, and ascitic fluids from patients with malignant and benign ovarian neoplasms. ## Methods: Ca125, tps, and sil-2ra